Procalcitonin biomarker kinetics fails to predict treatment response in perioperative abdominal infection with septic shock

Critical Care

Volumn 17, Issue 5, 2013, Pages

  Jung, Boris ^a,b   Molinari, Nicolas ^c   Nasri, Mourad ^a   Hajjej, Zied ^a   Chanques, Gerald ^a,b   Jean Pierre, Helene ^d   Panaro, Fabrizio ^a   Jaber, Samir ^a,b  

^a HÔPITAL SAINT ELOI   (France)

^b UNIV MONTPELLIER   (France)

^c Montpellier 1 University   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ABDOMINAL DRAINAGE; ABDOMINAL INFECTION; AGED; ARTICLE; DEATH; DEMOGRAPHY; FEMALE; HEMATOMA; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HYPOTHESIS; INTENSIVE CARE UNIT; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEDICAL RECORD REVIEW; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOLOGICAL DRAINAGE; RADIOLOGY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SUPERINFECTION; TREATMENT FAILURE; TREATMENT RESPONSE; BLOOD; INTRAABDOMINAL INFECTIONS; METABOLISM; SHOCK, SEPTIC; TREATMENT OUTCOME;

AGED; ANTI-INFECTIVE AGENTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INTRAABDOMINAL INFECTIONS; MALE; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84887400812     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13082     Document Type: Article

References (33)

1. Goldmann DA, Weinstein RA, Wenzel RP, Tablan OC, Duma RJ, Gaynes RP, Schlosser J, Martone WJ. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996, 275:234-240. 10.1001/jama.1996.03530270074035, 8604178.
2. Chastre J, Wolff M, Fagon J-Y, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003, 290:2588-2598. 10.1001/jama.290.19.2588, 14625336.
3. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004, 125:1791-1799. 10.1378/chest.125.5.1791, 15136392.
4. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000, 162:505-511. 10.1164/ajrccm.162.2.9909095, 10934078.
5. Nobre V, Harbarth S, Graf J-D, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2007, 177:498-505.
6. Stolz D, Smyrnios N, Eggimann P, Pargger H, Thakkar N, Siegemund M, Marsch S, Azzola A, Rakic J, Mueller B, Tamm M. Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study. Eur Respir J 2009, 34:1364-1375. 10.1183/09031936.00053209, 19797133.
7. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality*. Crit Care Med 2006, 34:2596-2602. 10.1097/01.CCM.0000239116.01855.61, 16915118.
8. Luyt CE, Guérin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2004, 171:48-53.
9. Bouadma L, Luyt C-E, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474. 10.1016/S0140-6736(09)61879-1, 20097417.
10. Hochreiter M, Köhler T, Schweiger AM, Keck FS, Bein B, Von Spiegel T, Schroeder S. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 2009, 13:R83. 10.1186/cc7903, 2717450, 19493352.
11. Schroeder S, Hochreiter M, Koehler T, Schweiger A-M, Bein B, Keck FS, Spiegel T. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg 2008, 394:221-226.
12. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med 2011, 171:1322. 10.1001/archinternmed.2011.318, 21824946.
13. Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev 2012, 9. CD007498.
14. Agarwal R, Schwartz DN. Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review. Clin Infect Dis 2011, 53:379-387. 10.1093/cid/cir408, 21810753.
15. Kopterides P, Siempos II, Tsangaris I, Tsantes A, Armaganidis A. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trials. Crit Care Med 2010, 38:2229-2241. 10.1097/CCM.0b013e3181f17bf9, 20729729.
16. Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 2007, 142:134-142. 10.1001/archsurg.142.2.134, 17309964.
17. Reith HB, Mittelkötter U, Wagner R, Thiede A. Procalcitonin (PCT) in patients with abdominal sepsis. Intensive Care Med 2000, 26:165-169.
18. Mofidi R, Suttie SA, Patil PV, Ogston S, Parks RW. The value of procalcitonin at predicting the severity of acute pancreatitis and development of infected pancreatic necrosis: systematic review. Surgery 2009, 146:72-81. 10.1016/j.surg.2009.02.013, 19541012.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
20. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC, Baron EJ, O'Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:133-164. 10.1086/649554, 20034345.
21. Novotny A, Emmanuel K, Hueser N, Knebel C, Kriner M, Ulm K, Bartels H, Siewert J, Holzmann B. Procalcitonin ratio indicates successful surgical treatment of abdominal sepsis. Surgery 2009, 145:20-26. 10.1016/j.surg.2008.08.009, 19081471.
22. Babinchak T, Ellis-Grosse E, Dartois N, Rose GM, Loh E. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 2005, 41:S354-S367. 10.1086/431676, 16080073.
23. Oliva ME, Rekha A, Yellin A, Pasternak J, Campos M, Rose GM, Babinchak T, Ellis-Grosse EJ, Loh E. A multicenter trial of the efficacy and safety of tigecycline versus imipenem/cilastatin in patients with complicated intra-abdominal infections [Study ID Numbers: 3074A1-301-WW; ClinicalTrials.gov Identifier: NCT00081744]. BMC Infect Dis 2005, 5:88. 10.1186/1471-2334-5-88, 1277826, 16236177.
24. Jung B, Chanques G, Ghiba M, Cisse M, Rossel N, Perrigault P-F, Souche B, Jean-Pierre H, Jaber S. [Tigecycline for treatment of severe infections in intensive care: a drug use evaluation]. Ann Fr Anesth Reanim 2010, 29:354-360. 10.1016/j.annfar.2010.02.002, 20347565.
25. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
26. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009, 302:2323-2329. 10.1001/jama.2009.1754, 19952319.
27. Jung B, Embriaco N, Roux F, Forel J-M, Demory D, Allardet-Servent J, Jaber S, La Scola B, Papazian L. Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med 2010, 36:790-798. 10.1007/s00134-010-1833-5, 20217042.
28. Twisk J, de Boer M, de Vente W, Heymans M. Multiple imputation of missing values was not necessary before performing a longitudinal mixed-model analysis. J Clin Epidemiol 2013, 66:1022-1028. 10.1016/j.jclinepi.2013.03.017, 23790725.
29. Luyt C-E, Combes A, Reynaud C, Hekimian G, Nieszkowska A, Tonnellier M, Aubry A, Trouillet J-L, Bernard M, Chastre J. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008, 34:1434-1440. 10.1007/s00134-008-1112-x, 18421435.
30. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7:210-217. 10.1016/S1473-3099(07)70052-X, 17317602.
31. Clec'h C, Fosse J-P, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34:102-107. 10.1097/01.CCM.0000195012.54682.F3, 16374163.
32. Svoboda P, Kantorová I, Scheer P, Radvanova J, Radvan M. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?. Hepatogastroenterology 2007, 54:359-363.
33. Guan J, Lin Z, Lue H. Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10 ng/mL. Shock 2011, 36:570-574. 10.1097/SHK.0b013e31823533f9, 21937947.